Sort
130,381 grants matching “hiv”
Small Molecular Inactivators of HIV
$1,034,506Daniel H Appella · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Small Molecular Inactivators of HIV
$1,034,506Daniel H Appella · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Preclinical Evaluation of Novel Ad/MVA and Ad/Protein HIV-1 Vaccines
$1,034,318Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2012 · AI
VIRAL AND IMMUNE CONSEQUENCES OF EARLY HIV1 THERAPY
$1,034,303Aaron Diamond Aids Research Center · U01 · FY2000 · AI
The Role Of Innate Immunity Genes In Viral Infection and Disease Progression
$1,034,084Steven R Kleeberger · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
International Tuberculosis Clinical Research
$1,034,058Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
CENTER FOR METABOLIC RESEARCH ON HIV AND DRUG USE
$1,034,035Sherwood L Gorbach · Tufts University Boston · P30 · FY2006 · DA
CITY Health II Center for the Study of Community Health
$1,034,000Max Michael · University Of Alabama At Birmingham · U48 · FY2016 · DP
MOLECULAR MECHANISMS OF HIV1 ASSOCIATED ENCEPHALOPATHY
$1,033,991St. Luke'S-Roosevelt Inst For Hlth Scis · P01 · FY2000 · NS
Pediatric AIDS Clinical Trials Group
$1,033,769St. Jude Children'S Research Hospital · U01 · FY2004 · AI
Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)
$1,033,724Philip Todd Korthuis · Oregon Health & Science University · U01 · FY2021 · TR
Training in Biomedical Informatics at Columbia University
$1,033,704Noemie Elhadad · Columbia University Health Sciences · T15 · FY2025 · LM
CENTER FOR METABOLIC RESEARCH ON HIV AND DRUG USE
$1,033,700Tufts University Boston · P30 · FY2005 · DA
COMMUNITY OPINION LEADER INTERVENTION TRIAL RAKAI-UGANDA
$1,033,606Columbia University Health Sciences · U10 · FY2000 · MH
Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block rebound
$1,033,535Priyamvada Acharya · Duke University · U54 · FY2025 · AI
Global Cancer Health
$1,033,509Philip Castle · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Clinical Trials of Patients with AIDS-Related Malignancies
$1,033,298Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
CITY Health II Center for the Study of Community Health
$1,033,000Max Michael · University Of Alabama At Birmingham · U48 · FY2015 · DP
The mucosal immune system: effects of aging and chronic antigenic stimulation
$1,032,611Rita Brickman Effros · University Of California Los Angeles · R01 · FY2010 · AG
Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U
$1,032,577Jowanna Malone · Whitman-Walker Institute, Inc. · R01 · FY2025 · AI
Novel CSF biomarker to predict impaired cognition in HIV
$1,032,541Dana Giulian · Inflame Therapeutics, Inc. · R42 · FY2006 · NS
Vancouver Drug Users Study: Evaluating the Natural History of Injection Drug Use
$1,032,518Thomas Kerr · University Of British Columbia · U01 · FY2016 · DA
Collaborative Research on Drug Abuse
$1,032,502Peter M Bentler · University Of California Los Angeles · P01 · FY2009 · DA
Clinical trials of patients with AIDS-related malignancies
$1,032,501Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$1,032,476Johns Hopkins University · U01 · FY2004 · AI